Promotional Trial Period definition

Promotional Trial Period means the one (1) year period following date of promotion to Deputy Sheriff III or Deputy Sheriff IV during which time the promoted employee may be returned to a Deputy Sheriff II/III from which they came position by decision of either the Sheriff or the affected employee. Such trial period demotions made by the Sheriff shall not be grievable under Article VI of this agreement nor appealable to the Civil Service Commission.
Sample 1Sample 2Sample 3
Promotional Trial Period. For securing the most effective adjustment of the employee and determining that the employee's performance meets the standards required of the new position, all promotions shall be made for a trial period of at least twelve (12) months. A department head may extend the trial period, with approval of the Town Manager, for an additional period of time, not to exceed a total of eighteen (18) months. The trial period for the employee shall be set forth in the letter of promotion. During the trial period, the department head shall; evaluate the performance of the promotee on a quarterly basis in consultation with the employee's own direct supervisor; provide written evaluations to the promotee and Town Manager; discuss with the promotee, the area(s) in which performance improvement is needed; and assist the promotee in correcting any deficiencies.
Sample 1

Examples of Promotional Trial Period in a sentence

  • End of Promotional Trial Period Employee Type FTE Promotional Date Illustrative Trial Period Length in Months Illustrative Trial Period Start Date End of Trial Period Illustrative End of promotional trial period increase Illustrative new rate of pay Promotional Position 1 2/5/2016 6 5/1/2016 10/31/2016 2.25% $18.84 Step 5.

  • Employee Promoted Employee Type FTE Illustrative Promotional Date Illustrative Promotional Increase Illustrative Rate of Pay after promotional Increase Illustrative Length of Promotional Trial Period in Months (begins after the new hire probationary period ends) Promotional Position 1 2/5/2016 6.00% $18.02 6 Step 3.

  • Unit members who are promoted to a higher classification shall serve a "Promotional Trial Period," established by the Superintendent, which shall be no longer than six (6) months in paid status in the new classification.

  • Employees who received a non-voluntary demotion within the last 24 months are ineligible.Promoted employees will serve a Promotional Trial Period Probation, per Rule 5, Regulation 2: Trial Period Probations.

  • End of Promotional Trial Period Employee Type FTE Promotional Date Illustrative Trial Period Length InMonths Illustrative Trial Period Start Date End of Trial Period Illustrative End of Promotional TrialPeriod Increase Illustrative New Rate of Pay Promotional Position 1 2/5/2016 6 5/1/2016 10/31/2016 2.25% $1 8.84 Step 5.

  • J., Vazquez, D., Lopez, A., Amores, J., Leibe, B.: Random forests of local experts for pedestrian detection.

  • In line with the requirements of Article 17, the present report examines the appropriateness of the levels of fees and market developments with a focus on the entry of new players, new technologies and innovative business models, the development of cross- border acquiring, the pass-through of fee reductions to consumers, the effects of co-badging, of the exclusion of commercial cards and other technical requirements.

  • The employee shall receive a non-competitive promotion (to the II level in the series) upon successful completion of the one-year probationary period and the achievement of permanency, and will be evaluated between April 15 and June 30 each year.b) Promotional Trial Period.

Related to Promotional Trial Period

  • Trial Period means a working test period after promotion, voluntary demotion, or intra-agency lateral transfer during which a classified employee is required to demonstrate satisfactory performance in the job to which promoted, voluntarily demoted, or transferred before acquiring permanent status in the job.

  • Promotion Period means the period the Promotion is open, as specified in clause 5.1.

  • Co-Promotion means those promotional activities undertaken by a ------------ pharmaceutical company's sales force in concert with at least one other pharmaceutical company's sales force to implement the marketing plans and strategies with respect to a particular prescription pharmaceutical product under a single trademark. When used as a verb, "Co-Promote" shall mean to engage ---------- in such activities.

  • Development Period means the period from the date of this Agreement until the Appointed Date;

  • Development Term means the period commencing on the Closing Date and ending on the earlier of (a) the Option Closing Date or (b) the date the Option terminates or expires other than by exercise.

  • Research Period means the research period as described in the Commissioned Research Plan. In accordance with the provisions of this Agreement, in the event that the Agreement ended prior to the completion date of the research originally set, the date the Agreement ends shall be read as the research period.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Initial Period means the period from (and including) the Issue Date to (but excluding) the First Call Date;

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Traditional Territory means, subject to a Yukon First Nation Final Agreement, with respect to each Yukon First Nation and each Yukon Indian Person enrolled in that Yukon First Nation's Final Agreement, the geographic area within the Yukon identified as that Yukon First Nation's Traditional Territory on the map referred to in 2.9.0.

  • Program Period means the period of time which the department intends to support the program without requiring the recompetition for funds. The program period is specified within the grant application.

  • Phase III Clinical Trial means a human clinical trial, the principal purpose of which is to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more indications in order to obtain Marketing Approval of such Licensed Product for such indication(s), as further defined in 21 C.F.R. §312.21 or a similar clinical study in a country other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase IV Clinical Trial means a Clinical Trial conducted after a Product achieves Regulatory Approval, carried out for purposes of conducting safety surveillance and ongoing technical support of the Product.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Collaboration Term has the meaning set forth in Section 2.1(h).

  • JCC has the meaning set forth in Section 2.1.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Development Period Security shall have the meaning set forth in Section 6.1(a) hereof.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.